More importantly, as shown in Fig. 1E, the CRC xenograft tumor growth of these stable transfectants was clearly impaired in vivo when CBX8 was knocked down in both HCT116 and HT29 cells. This evidence concerns the gene CBX8 and colorectal carcinoma.